Differentiating agents modulate topoisomerase I activity in U-937 promonocytic cells
Phorbol 12-myristate 13-acetate (PMA), N,N'-hexamethylenebisacetamide (HMBA) and retinoic acid induce cell differentiation in U-937 promonocytic cells. This report examines the effects of these agents on DNA topoisomerase I activity. A decrease in enzyme activity could be detected as early as 3...
Guardado en:
| Autor principal: | |
|---|---|
| Otros Autores: | , |
| Formato: | Capítulo de libro |
| Lenguaje: | Inglés |
| Publicado: |
1997
|
| Acceso en línea: | Registro en Scopus DOI Handle Registro en la Biblioteca Digital |
| Aporte de: | Registro referencial: Solicitar el recurso aquí |
| LEADER | 06908caa a22008897a 4500 | ||
|---|---|---|---|
| 001 | PAPER-20075 | ||
| 003 | AR-BaUEN | ||
| 005 | 20230518205128.0 | ||
| 008 | 190411s1997 xx ||||fo|||| 00| 0 eng|d | ||
| 024 | 7 | |2 scopus |a 2-s2.0-0031564605 | |
| 024 | 7 | |2 cas |a Acetamides; Antineoplastic Agents; Carcinogens; DNA Topoisomerases, Type I, EC 5.99.1.2; hexamethylene bisacetamide, 3073-59-4; Tetradecanoylphorbol Acetate, 16561-29-8; Tretinoin, 302-79-4 | |
| 040 | |a Scopus |b spa |c AR-BaUEN |d AR-BaUEN | ||
| 030 | |a EJPHA | ||
| 100 | 1 | |a Shayo, C.C. | |
| 245 | 1 | 0 | |a Differentiating agents modulate topoisomerase I activity in U-937 promonocytic cells |
| 260 | |c 1997 | ||
| 270 | 1 | 0 | |m Baldi, A.; Institute of Biology, CONICET, Obligado 2490, 1428 Buenos Aires, Argentina |
| 506 | |2 openaire |e Política editorial | ||
| 504 | |a Aller, P., Rius, C., Mata, F., Zorrilla, A., Cabañas, C., Bellón, T., Bernabeu, C., Camptothecin induces differentiation and stimulates the expression of differentiation-related genes in U-937 human promonocytic leukemia cells (1992) Cancer Res., 52, pp. 1245-1251 | ||
| 504 | |a Andreeff, M., Stone, R., Michaeli, J., Young, C.W., Tong, W.P., Sogoloff, H., Ervin, T., Marks, P.A., Hexamethylenebisacetamide in myelodysplastic syndrome and acute myelogenous leukemia: A phase II clinical trial with a differentiation-inducing agent (1992) Blood, 80, pp. 2604-2609 | ||
| 504 | |a Baldi, A., Crespi, M.D., Castro, G., Wittliff, J.L., Shayo, C.C., Annibali, N.V., Mladovan, A.G., Molecular mechanism implicated in the control of cell growth in human breast cancer cells treated with phorbol esters (1993) Biocell, 17, pp. 133-144 | ||
| 504 | |a Bernstein, S.H., Sherman, M.L., Hass, R., Nakamura, T., Kharbanda, S., Kufe, D.W., Effects of hexamethylenebisacetamide on induction of monocytic differentiation of human U-937 myeloid leukemia cells (1991) Biochem. Pharmacol., 42, pp. 403-407 | ||
| 504 | |a Cardellini, E., Durban, E., Phosphorylation of human topoisomerase I by protein kinase C in vitro and in phorbol 12-myristate 13-acetate-activated HL60 promyelocytic leukemia cells (1993) Biochem. J., 291, pp. 303-307 | ||
| 504 | |a Collins, S.J., The HL-60 promyelocytic leukemia cell line: Proliferation, differentiation, and cellular oncogene expression (1987) Blood, 70, pp. 1233-1244 | ||
| 504 | |a Crespi, M.D., Mladovan, A.G., Baldi, A., Increment of DNA topoisomerases in chemically and virally transformed cells (1988) Exp. Cell Res., 175, pp. 206-215 | ||
| 504 | |a Grignani, F., Fagioli, M., Alcalay, M., Longo, L., Pandolfi, P., Donti, E., Biondi, A., Pelicci, P.G., Acute promyelocytic leukemia: From genetics to treatment (1994) Blood, 83, pp. 10-25 | ||
| 504 | |a Kolset, S.O., Ivhed, I., Overvatn, A., Nilsson, K., Differentiation-associated changes in the expression of chondroitin sulfate proteoglycan in induced U937 cells (1988) Cancer Res., 48, pp. 6103-6108 | ||
| 504 | |a Kretzschmar, M., Meisterernst, M., Roeder, R.G., Identification of human DNA topoisomerase I as a cofactor for activator-dependent transcription by RNA polymerase II (1993) Proc. Natl. Acad. Sci. USA, 90, pp. 11508-11512 | ||
| 504 | |a Mattern, M.R., Mong, S., Mong, S.M., Bartus, J.O'L., Sarau, H.M., Clark, M.A., Foley, J.J., Crooke, S.T., Transient activation of topoisomerase I in leukotriene D4 signal transduction in human cells (1990) Biochem. J., 265, pp. 101-107 | ||
| 504 | |a Olsson, I.L., Breitman, T.R., Induction of differentiation of the human histiocytic cell line U-937 by retinoic acid and cyclic adenosine 3′,5′-monophosphate-inducing agents (1982) Cancer Res., 42, pp. 3924-3927 | ||
| 504 | |a Pommier, Y., Kerrigan, D., Hartman, K.D., Glazer, R.I., Phosphorylation of mammalian DNA topoisomerase I and activation by protein kinase C (1990) J. Biol. Chem., 265, pp. 9418-9422 | ||
| 504 | |a Wang, J.C., DNA topoisomerases (1996) Annu. Rev. Biochem., 65, pp. 635-692 | ||
| 520 | 3 | |a Phorbol 12-myristate 13-acetate (PMA), N,N'-hexamethylenebisacetamide (HMBA) and retinoic acid induce cell differentiation in U-937 promonocytic cells. This report examines the effects of these agents on DNA topoisomerase I activity. A decrease in enzyme activity could be detected as early as 30 min after treatment with all three differentiating compounds and lasted at least 48 h. No alteration in the levels of DNA topoisomerase I transcript or protein was observed during these treatments. The results might be explained by post-translational events that render DNA topoisomerase type I less active. |l eng | |
| 536 | |a Detalles de la financiación: National Research Council | ||
| 536 | |a Detalles de la financiación: Consejo Nacional de Investigaciones Científicas y Técnicas | ||
| 536 | |a Detalles de la financiación: This work was supported by grants from the National Research Council (CONICET) and from the Argentine League Against Cancer (LALCEC). | ||
| 593 | |a Inst. of Biol. and Exp. Med.-CONICET, Obligado 2490, 1428 Buenos Aires, Argentina | ||
| 690 | 1 | 0 | |a DIFFERENTIATION |
| 690 | 1 | 0 | |a TOPOISOMERASE I |
| 690 | 1 | 0 | |a U-937 CELL |
| 690 | 1 | 0 | |a 4ALPHA PHORBOL |
| 690 | 1 | 0 | |a DNA TOPOISOMERASE |
| 690 | 1 | 0 | |a HEXAMETHYLENEBISACETAMIDE |
| 690 | 1 | 0 | |a PHORBOL 13 ACETATE 12 MYRISTATE |
| 690 | 1 | 0 | |a RETINOIC ACID |
| 690 | 1 | 0 | |a ARTICLE |
| 690 | 1 | 0 | |a CELL DIFFERENTIATION |
| 690 | 1 | 0 | |a CONTROLLED STUDY |
| 690 | 1 | 0 | |a ENZYME ACTIVITY |
| 690 | 1 | 0 | |a HUMAN |
| 690 | 1 | 0 | |a HUMAN CELL |
| 690 | 1 | 0 | |a LEUKEMIA CELL |
| 690 | 1 | 0 | |a PRIORITY JOURNAL |
| 690 | 1 | 0 | |a ACETAMIDES |
| 690 | 1 | 0 | |a ANTINEOPLASTIC AGENTS |
| 690 | 1 | 0 | |a BLOTTING, NORTHERN |
| 690 | 1 | 0 | |a BLOTTING, WESTERN |
| 690 | 1 | 0 | |a CARCINOGENS |
| 690 | 1 | 0 | |a CELL TRANSFORMATION, NEOPLASTIC |
| 690 | 1 | 0 | |a DNA TOPOISOMERASES, TYPE I |
| 690 | 1 | 0 | |a ELECTROPHORESIS, POLYACRYLAMIDE GEL |
| 690 | 1 | 0 | |a HUMANS |
| 690 | 1 | 0 | |a LEUKEMIA, MONOCYTIC, CHRONIC |
| 690 | 1 | 0 | |a TETRADECANOYLPHORBOL ACETATE |
| 690 | 1 | 0 | |a TRANSCRIPTION, GENETIC |
| 690 | 1 | 0 | |a TRETINOIN |
| 690 | 1 | 0 | |a TUMOR CELLS, CULTURED |
| 700 | 1 | |a Mladovan, A.G. | |
| 700 | 1 | |a Baldi, A. | |
| 773 | 0 | |d 1997 |g v. 324 |h pp. 129-133 |k n. 1 |p EUR. J. PHARMACOL. |x 00142999 |w (AR-BaUEN)CENRE-1772 |t European Journal of Pharmacology | |
| 856 | 4 | 1 | |u https://www.scopus.com/inward/record.uri?eid=2-s2.0-0031564605&doi=10.1016%2fS0014-2999%2897%2900151-9&partnerID=40&md5=bd83a3a0b62865a500266ddd7e0f0d52 |y Registro en Scopus |
| 856 | 4 | 0 | |u https://doi.org/10.1016/S0014-2999(97)00151-9 |y DOI |
| 856 | 4 | 0 | |u https://hdl.handle.net/20.500.12110/paper_00142999_v324_n1_p129_Shayo |y Handle |
| 856 | 4 | 0 | |u https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_00142999_v324_n1_p129_Shayo |y Registro en la Biblioteca Digital |
| 961 | |a paper_00142999_v324_n1_p129_Shayo |b paper |c PE | ||
| 962 | |a info:eu-repo/semantics/article |a info:ar-repo/semantics/artículo |b info:eu-repo/semantics/publishedVersion | ||
| 999 | |c 81028 | ||